What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Scientists are exploring age related muscle decline studies, using the compounds exercise-mimetic effects on muscle tissue and mitochondrial function
By keeping peptide production closer to home, we can better control product standards, reduce reliance on uncertain imported inventory, and provide Canadian researchers with a more transparent and reliable source for research peptides
What are the different routes of administration for B12 injections, and how do they impact dosing
However, it is important to note that B12 injections should only be given under the supervision of a healthcare professional